Masimo (MASI) Net Income Growth (5y) (2014 - 2026)
Masimo (MASI) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -56.83% |
| Jan 3, 2026 | -33.51% |
| Sep 27, 2025 | -38.62% |
| Jun 28, 2025 | -35.14% |
| Mar 29, 2025 | -40.01% |
| Dec 28, 2024 | -49.14% |
| Sep 28, 2024 | -18.08% |
| Jun 29, 2024 | -17.04% |
| Mar 30, 2024 | -17.79% |
| Dec 30, 2023 | 5.07% |
| Sep 30, 2023 | -28.60% |
| Jul 1, 2023 | -18.57% |
| Apr 1, 2023 | -14.13% |
| Dec 31, 2022 | 48.77% |
| Oct 1, 2022 | 1.12% |
| Jul 2, 2022 | -16.70% |
| Apr 2, 2022 | -1.99% |
| Jan 1, 2022 | -23.29% |
| Oct 2, 2021 | 15.79% |
| Jul 3, 2021 | 10.83% |